Less frequent catheter dressing changes decrease local cutaneous toxicity of high-dose chemotherapy in children, without increasing the rate of catheter-related infections: Results of a randomised trial

Bone Marrow Transplantation

Volumn 29, Issue 8, 2002, Pages 653-658

  Benhamou, E ^a   Fessard, E ^a   Com Nougue C ^a   Beaussier, P S ^a   Nitenberg, G ^a   Tancrede C ^a   Dodeman, S ^a   Hartmann, O ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Bone marrow transplantation; Catheter dressings; Catheter related infection; Randomised trial; Skin toxicity

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CHLORHEXIDINE; EOSIN; MELPHALAN; POVIDONE IODINE; THIOTEPA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CATHETER INFECTION; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG MEGADOSE; EWING SARCOMA; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INFECTION RISK; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; NEUROBLASTOMA; PAIN; PRIORITY JOURNAL; QUALITATIVE DIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; RHABDOMYOSARCOMA; SKIN CULTURE; SKIN TOXICITY; STATISTICAL ANALYSIS; WOUND DRESSING; BANDAGE; BONE MARROW TRANSPLANTATION; DRUG EFFECT; INDWELLING CATHETER; INFECTION; NEOPLASM; PATHOLOGY; PRESCHOOL CHILD; SKIN; TIME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BANDAGES; BONE MARROW TRANSPLANTATION; CATHETERS, INDWELLING; CHILD; CHILD, PRESCHOOL; FEMALE; HUMAN; INFECTION; MALE; NEOPLASMS; SKIN; TIME FACTORS; HUMANS;

EID: 0036015535     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703511     Document Type: Article

References (23)

1. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, transparent polyurethane dressing, and an iodophortransparent dressing
2. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: Implications for catheter management
3. High-dose busulfan and thiotepa with autologous bone marrow transplantation in childhood malignant brain tumors: A phase II study
4. Enhanced cutaneous radiation effects following high-dose busulfan therapy
5. Anti-infective prophylaxis with ceftazidine and teicoplanin in children undergoing high-dose chemotherapy and bone marrow transplantation
6. Predictive value of surveillance skin cultures in total-parenteral-nutrition-related infection
7. Association between microorganism growth at the catheter insertion site and the colonisation of the catheter in patients receiving total parenteral nutrition
8. Skin versus hub cultures to predict colonization and infection of central venous catheter in intensive care patients
9. An improved approximate formula for calculating sample size for comparing two binomial distributions
10. Non parametric estimations from incomplete observations
11. Estimation of confidence limits for the cumulative probability of survival in life table analysis
12. Asymptotically efficient rank invariant test procedures
13. Pathogenesis of infections related to intravascular catheterization
14. Increased incidence of central venous catheter-related infections in bone marrow transplant patients
15. Complications infectieuses liées aux abords veineux centraux
16. Lack of clinical benefit from subcutaneous tunnel insertion central venous catheters in immunocompromised patients
17. Catheter-related infections in pediatric patients
18. Infections due to infusion therapy
19. Laboratory clinical and epidemiological aspects of coagulase-negative staphylococci
20. Change of central venous catheter dressing twice a week is superior to once a week in patients with haematological malignancies
21. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: An overview
22. Guideline for prevention of intravascular device-related infections. Part II. Recommendations for the prevention of nosocomial intravascular device-related infections